Dietary Antioxidant Intake and Risk of Type 2 Diabetes
Response to Granado-Lorencio and Olmedilla-Alonso
- Jukka Montonen, MSC1,
- Paul Knekt, PHD12,
- Ritva Järvinen, PHD3 and
- Antti Reunanen, MD, PHD1
- 1Department of Health and Functional Capacity, National Public Health Institute, Helsinki, Finland
- 2Social Insurance Institution, Helsinki and Turku, Finland
- 3Department of Clinical Nutrition, University of Kuopio, Kuopio, Finland
- Address correspondence to Jukka Montonen, National Public Health Institute, Department of Health and Functional Capacity, Mannerheimintie 166, 00300 Helsinki, Finland. E-mail: jukka.montonen{at}ktl.fi
We would like to express our warm thanks to Granado-Lorencio and Olmedilla-Alonso for carefully reading our article (1) and for their comments regarding the inverse association between β-cryptoxanthin intake and diabetes risk (2). Granado-Lorencio and Olmedilla-Alonso pointed out that the β-cryptoxanthin intake in our study population was exceptionally low; therefore, any potential beneficial effect associated with such low amounts of β-cryptoxanthin is difficult to imagine.
In …
